ALDOMET Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Aldomet, and when can generic versions of Aldomet launch?
Aldomet is a drug marketed by Merck and is included in three NDAs.
The generic ingredient in ALDOMET is methyldopa. There are nineteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methyldopa profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ALDOMET?
- What are the global sales for ALDOMET?
- What is Average Wholesale Price for ALDOMET?
Summary for ALDOMET
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 3 |
| Raw Ingredient (Bulk) Api Vendors: | 96 |
| Clinical Trials: | 8 |
| Patent Applications: | 5,095 |
| DailyMed Link: | ALDOMET at DailyMed |
Recent Clinical Trials for ALDOMET
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Maastricht University Medical Center | Phase 4 |
| Bill and Melinda Gates Foundation | N/A |
US Patents and Regulatory Information for ALDOMET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | ALDOMET | methyldopate hydrochloride | INJECTABLE;INJECTION | 013401-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | ALDOMET | methyldopa | TABLET;ORAL | 013400-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | ALDOMET | methyldopa | SUSPENSION;ORAL | 018389-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | ALDOMET | methyldopa | TABLET;ORAL | 013400-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Merck | ALDOMET | methyldopa | TABLET;ORAL | 013400-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ALDOMET
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | ALDOMET | methyldopa | SUSPENSION;ORAL | 018389-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
